Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 May 1;22(9):3326-31.
doi: 10.1523/JNEUROSCI.22-09-03326.2002.

Cannabinoid addiction: behavioral models and neural correlates

Affiliations
Review

Cannabinoid addiction: behavioral models and neural correlates

Rafael Maldonado et al. J Neurosci. .

Abstract

The use of cannabis sativa preparations as recreational drugs can be traced back to the earliest civilizations. However, animal models of cannabinoid addiction allowing the exploration of neural correlates of cannabinoid abuse have been developed only recently. We review these models and the role of the CB1 cannabinoid receptor, the main target of natural cannabinoids, and its interaction with opioid and dopamine transmission in reward circuits. Extensive reviews on the molecular basis of cannabinoid action are available elsewhere (Piomelli et al., 2000; Schlicker and Kathmann, 2001).

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Molecular targets of major abused drugs. Cannabinoids, like opiates, activate a G-protein-coupled receptor, in this case the CB1R, which couples to transduction mechanisms, mainly adenylyl cyclase (AC), and voltage-gated potassium, and calcium channels through the small GTP-binding proteins Gs/olf and Gi/o. CB1 receptors thereby modulate the resting membrane potential and intracellular concentrations of cAMP. Subsequent modification of the activity of specific protein kinases, primarily PKA, but also mitogen-activated protein kinases, leads to both acute responses (modulation of neurotransmitter release or firing rates) and long-term adaptations associated with dependence and withdrawal.
Fig. 2.
Fig. 2.
Involvement of the endogenous opioid system in cannabinoid motivational properties, tolerance, and dependence. A, THC-induced CPP is abolished in MOR KO mice. Scores are calculated as the difference between test and preconditioning time spent in the drug-paired compartment (fromGhozland et al., 2002). B, Tolerance to THC-induced antinociception is reduced in KO mice deficient in the pre-proenkephalin gene (from Valverde et al., 2000). C, Severity of SR141716A-precipitated THC withdrawal syndrome is attenuated in KO mice deficient in the pre-proenkephalin gene. A global withdrawal score was calculated for each animal by giving each individual sign (tremor, wet dog shakes, ptosis, front paw tremor, ataxia, mastication, hunched posture, sniffing, piloerection, and penile lick) a proportional weight (from Valverde et al., 2000). Values are expressed as mean ± SEM; ▸▸ p < 0.05, ▸▸▸▸ p < 0.01, comparison between treatments; ◂◂ p < 0.05, ◂◂◂◂ p < 0.01, comparison between genotypes (one-way ANOVA).

Comment in

References

    1. Abood ME, Martin BR. Neurobiology of marijuana abuse. Trends Pharmacol Sci. 1992;13:201–207. - PubMed
    1. Aceto MD, Scates SM, Lowe JA, Martin BP. Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther. 1996;278:1290–1295. - PubMed
    1. Aceto MD, Scates SM, Lowe JA, Martin BP. Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55,212-2. Eur J Pharmacol. 2001;416:75–81. - PubMed
    1. Arnold JC, Hunt GE, McGregor IS. Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sci. 2001;70:97–108. - PubMed
    1. Bass CE, Martin BR. Time course for the induction and maintenance of tolerance to delta-9-tetrahydrocannabinol in mice. Drug Alcohol Depend. 2000;60:113–119. - PubMed

Publication types